Meeting
2019 ASCO Annual Meeting
The 55 STAR study: Prognostic and predictive value of the 55-gene classifier (55GC) in stage III colon cancer.
Authors
Toshiaki Ishikawa
Tokyo Medical and Dental University, Tokyo, Japan
Toshiaki Ishikawa , Eiji Oki , Eiji Shinto , Mototsugu Shimokawa , Shigeki Yamaguchi , Megumi Ishiguro , Seiji Hasegawa , Yasumasa Takii , Hideyuki Ishida , Tetsuya Kusumoto , Masaru Morita , Naohiro Tomita , Manabu Shiozawa , Masafumi Tanaka , Heita Ozawa , Yojiro Hashiguchi , Shinobu Ohnuma , Sachiyo Tada , Tomoko Matsushima , Kazuo Hase
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3597)
DOI
10.1200/JCO.2019.37.15_suppl.3597
Abstract #
3597
Poster Bd #
89
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Cost-effectiveness of adjuvant chemotherapy for patients with high-risk stage II and stage III colon cancer in South Africa.
First Author: Yoanna S Pumpalova
Poster
2020 Gastrointestinal Cancers Symposium
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis.
First Author: Suganija Lakkunarajah
Poster
2018 Gastrointestinal Cancers Symposium
Early survival outcomes in stage I-III operated colon cancer patients from a low prevalence, lower-middle income country: The Indian experience.
First Author: Rushabh Kiran Kothari
Poster
2018 Gastrointestinal Cancers Symposium
Clinical impact of diverting ileostomy on the dose intensity of adjuvant chemotherapy for colorectal cancer.
First Author: Shusuke Yagi